Market View

The major indices accumulated two more days of institutional selling, as the S&P 500 and Nasdaq declined by 1.5% and 3.1%, respectively. The Health Care sector, primarily drug-related industries, led the market lower, which put pressure on many of the sector’s leaders from the prior uptrend. Indices and many stocks on the U.S. Focus List are trading at or near their moving averages and testing prior support levels.

Market View

U.S. indices rallied over 2% on Tuesday, on volume greater than the previous day, signaling a Day 9 follow-through day. There are multiple things we are looking for subsequent to this new rally confirmation. The most important thing is newly actionable ideas from fundamentally sound companies. Currently, the majority of big price moves have been coming from beaten down sectors that still need quite a bit of work before becoming ac-tionable again. Most critical is to see ideas that participated during the last cycle firm up and retake resistance levels, while new ideas also begin to emerge.

Global Sell-Off Resumes

Twenty-three developed markets lost 2.6% this week, failing to build on strong mid- to late-week gains in the prior week. All markets fell, except Ireland, which gained 1.3%. Sixteen markets lost at least 2%, 10 lost at least 3%, and four (Australia, Japan, Portugal, and Spain) lost at least 4%.

Market View

The U.S. market continues to chop around with high volatility. Leadership ideas are forming new bases, with the majority trading below resistance at their respective 10-week or even 40-week moving averages. This justifies a defensive approach that avoids any new buys at the moment. The indices remain above last Wednesday’s low, so we are monitoring for new leadership ideas to emerge, especially ones that did not participate in the prior uptrend. A new follow-through day, combined with multiple actionable ideas, would give us confidence that this correction is over. Now we are on Day 8 of a Rally Attempt, with no actionable ideas.